![Compliance Tool: Model Mandatory Excluded Provider Screening Policy](https://www.g2intelligence.com/wp-content/uploads/2023/05/June23.LCA_.TOOL_.ScreeningPolicy-iStock-1451809870-1100x800-1-1080x675.jpg)
Compliance Tool: Model Mandatory Excluded Provider Screening Policy
A written policy helps establish your right to do excluded persons checks and take appropriate actions if they come back positive.
A written policy helps establish your right to do excluded persons checks and take appropriate actions if they come back positive.
In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.
The new codes have garnered attention as a future mechanism for additional reimbursement and thus deserve further discussion.
Hiring, retaining, or simply doing business with the wrong people may expose your lab to significant financial penalties.
Christian Olsen, a leader in R&D scientific software, discusses recent developments related to AI and solutions to current precision medicine challenges.
In early May, GSK’s Arexvy became the first RSV vaccine to be cleared by the FDA for use in the US in adults aged 60 and up.
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.
A simple blood test may help screen, identify, intervene, treat, monitor, and eventually, prevent PTSD.
A recent False Claims Act settlement from Kentucky represents an unusual variation on a common theme.
This panel will help laboratory owners make decisions now to be better positioned in the future for a potential sale.